PerkinElmer Unveils New Analytical Solutions at Pittcon 2006 to Drive Innovation, Precision and Reliability

Showcases "Smart Thinking" to Help Customers Overcome Complex Challenges

PerkinElmer Inc. (NYSE: PKI), a global leader in Health Sciencesand Photonics, today announced new application-based laboratorysolutions and product enhancements for the environmental,pharmaceutical, materials and academic research market segments atPITTCON(R) 2006, March 13-15, booth # 2669.

New, innovative solutions being showcased include five turnkeyOzone Precursor Analyzer systems for remote environmental airmonitoring. Combining the Clarus(R) 500 multidimensional GasChromatograph (GC) with PerkinElmer's recently introduced family ofTurboMatrix(TM) Thermal Desorbers, the new systems offer single-tubeor automated (50-tube) configurations with either manual or fullyintegrated programmable pneumatic control (PPC) for maximumease-of-use and reliability for ozone precursor and air toxicsanalyses.

PerkinElmer is also featuring its latest WinLab32(TM) for AtomicAbsorption (AA) software with an integrated Quality Control (QC)Charting option to provide customers with a convenient andcomprehensive solution for increasing flexibility and productivity.The QC Charting feature allows laboratories to quickly and easilyprepare quality control charts from results, as well as storecustomized templates for future use, without purchasing additional,third-party software.

"Solving complex analytical problems in today's demandinglaboratory environments requires innovation, precision andreliability," said Robert F. Friel, president of PerkinElmer Life andAnalytical Sciences. "Our new product introductions and enhancementsat PITTCON 2006 will help provide customers with 'smart thinking'solutions to create greater efficiency and accuracy in theirlaboratories."

Additional product introductions include Jade(TM) DSC. A newmember of the Company's Thermal Analysis line of heat-fluxDifferential Scanning Calorimeters, Jade DSC offers new features toexpand application capabilities and operating convenience for routineapplications, QA/QC and education, including: a liquid nitrogencooling system to automate low temperature testing; improved baselineflatness and stability to assure accurate measurements; and advancesin autosampler control to increase sample throughput and improveproductivity.

LABWORKS(TM) LIMS v5.9 will also be unveiled at the show. Thelatest version of PerkinElmer's LABWORKS laboratory informationmanagement system is the first release built on an entirely newcomputing platform. The new architecture takes LABWORKS' longtradition of highly-configurable systems to a new level of tailoring.Using a new implementation tool kit, users can customize site-specificdata structure and presentation of their LIMS. Version 5.9 alsoincludes expanded security features for greater regulatory compliancewith ISO 17025 and other standards.

Other products and services that will be showcased atPerkinElmer's booth at PITTCON include:

-- TurboMatrix(TM) 650 ATD - Incorporating PPC, this thermal desorber provides outstanding analytical performance in an automated sample-tube handling system for unattended analysis of up to 50 samples for monitoring volatile organic compounds, occupational health and safety, and environmental protection.

-- TurboMass(TM) 5.2 GC/MS Software - Assures method compliance and increased productivity in the environmental laboratory with expanded resources for evaluation and reporting Clarus(R) 500 GC/MS information, including a custom compound list capability that allows operators to run a full batch of samples and select which compounds are to be reported to each individual client.

-- The integrated Series 200 HPLC PDA System with IRIS(TM) Spectral Processing Software - Improves data quality and enhances laboratory workflow through its full suite of functionality and an intuitive user interface protected under a fully 21 CFR Part 11-compliant architecture. IRIS provides dedicated views for peak purity, spectral comparison, library search, signal extraction, and up to 10 chromatographic signals automatically extracted. Additionally, the IRIS software offers multi-level user permissions, password-protected access control, full audit trailing, as well as configurable e-signature points.

-- PerkinElmer's Spectrum(TM) 100 FT-IR and 100N FT-NIR Spectrometers - The Gold standard in FT-IR spectrometer performance enables laboratories to achieve the highest spectral quality and most reproducible results with ease and efficiency. The series encompasses a broad array of features and advantages, including a new and improved Universal Attenuated Total Reflectance (UATR) accessory, new fiber optic near infrared (NIR) probe, Go Button, and an enhanced version of PerkinElmer's Spectrum and AssureID(TM) software packages. This software provides a laboratory workflow-driven approach to testing materials for an easy-to-use measurement system that integrates seamlessly into operations in laboratories of any size.

-- PerkinElmer LAMBDA(TM) 950, 850 and 650 UV/Vis/NIR and UV/Vis Spectrophotometers - The industry standard for high performance, flexibility and convenience, each model includes the same unparalleled range of modular components and snap-in accessories to tackle the widest range of applications in the industry. The LAMBDA(TM) series includes the PerkinElmer Universal Reflectance Accessory (URA) - a breakthrough sampling accessory for absolute reflectance measurements at variable angles that automates angle changes, eliminates alignment issues, and permits instant switching between reference and sample.

-- PerkinElmer Spectrum(TM) Spotlight(TM) 300 FT-IR Imaging System - Enables rapid extraction and analysis of data on molecular composition from a wide range of materials, from pharmaceutical tablets, to diseased human tissues, to forensic evidence, to the most complex chemical materials. The system's speed, unmatched spatial resolution, spectral range and superior signal to noise ratio enable the Spotlight to deliver the highest quality chemical imaging data in the market.

-- AAnalyst(TM) 200 Touch-Screen-Software - The enhanced software includes sample identification and dilution factors, as well as improved control of the AS-93plus autosampler to help increase flexibility and ease-of-use. In addition, the expansion of the software's multiple-language capability includes three new languages - Greek, Portuguese and Polish - to help provide users with even more options to select their language of choice.

-- The JANUS(TM) Automated Workstation - With proprietary Modular Dispense Technology(TM) (MDT), the workstation delivers real-time and future adaptability in throughput, capacity and dynamic volume range without compromise in performance or methodology. JANUS provides a comprehensive, scalable platform with extended adaptability and functionality to meet customers' needs for complete assay automation.

-- OneSource(R) Professional Services - Provides the skills and capabilities to make laboratories more productive and efficient. Services include: project management; technical support; multi-vendor validation; multi-vendor maintenance; multi-vendor repair; asset management; eLearning programs; and local and international equipment and total lab moves.

Factors Affecting Future Performance

This press release contains "forward-looking" statements withinthe meaning of the Private Securities Litigation Reform Act of 1995,including, but not limited to, statements relating to estimates andprojections of future earnings per share and revenue growth and otherfinancial results, developments relating to our customers andend-markets, and plans concerning business development opportunities.Words such as "believes," "intends," "anticipates," "plans,""expects," "projects," "forecasts," "will" and similar expressions,and references to guidance, are intended to identify forward-lookingstatements. Such statements are based on management's currentassumptions and expectations and no assurances can be given that ourassumptions or expectations will prove to be correct. A number ofimportant risk factors could cause actual results to differ materiallyfrom the results described, implied or projected in anyforward-looking statements. These factors include, without limitation:(1) economic and geopolitical forces that may limit any continued orexpected economic or end market strengthening or recoveries; (2) risksrelated to our failure to introduce new products in a timely manner;(3) our ability to comply with financial covenants contained in ourcredit agreements and our debt instruments; (4) a delay in resolutionof the Company's tax audits and an adverse determination with respectto the Company's tax audits by the Internal Revenue Service or othertaxing authorities; (5) cyclical downturns continuing to affectseveral of the industries into which we sell our products; (6) ourability to adjust our operations to address unexpected changes; (7)our ability to execute acquisitions and license technologies andsuccessfully integrate acquired businesses and licensed technologiesinto our existing business; (8) the loss of any of our licenses thatmay require us to stop selling products or lose competitive advantage;(9) competition; (10) regulatory compliance; (11) regulatory changes;(12) our failure to obtain and enforce intellectual propertyprotection; (13) our defense of third party claims of patentinfringement and our ability to realize the full value of ourintangible assets; (14) other factors which we describe under thecaption "Forward-Looking Information and Factors Affecting FuturePerformance" in our most recent annual report on Form 10-K and in ourmost recent quarterly report on Form 10-Q and in our other filingswith the Securities and Exchange Commission. We disclaim any intentionor obligation to update any forward-looking statements as a result ofdevelopments occurring after the date of this press release.

Other Information

Health Sciences end markets include genetic screening,environmental, service, biopharma, and medical imaging. Photonicsmarkets include sensors and specialty lighting.

PerkinElmer, Inc. is a global technology leader driving growth andinnovation in Health Sciences and Photonics markets to improve thequality of life. The Company reported revenues of $1.5 billion in2005, has 8,000 employees serving customers in more than 125countries, and is a component of the S&P 500 Index. Additionalinformation is available through www.perkinelmer.com or1-877-PKI-NYSE.